All lobbying filings

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) filed a Q1 report for AMERICAN PHARMACIES, INC. on April 22, 2026, reporting $60,000 in lobbying income.

Lobbying for AMERICAN PHARMACIES, INC. · Independent pharmacy services group

All filings by ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) · Everything AMERICAN PHARMACIES, INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 22, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Pharmacy

Issues related to independent pharmacy, including insurance coverage, network, and reimbursement; S. 526, Pharmacy Benefit Transparency Act; H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act.

Medicare/Medicaid

Issues related to independent pharmacy, including Medicare and Medicaid reimbursement; H.R. 1, One Big Beautiful Bill Act; H.R. 4317, Pharmacy Benefit Manager (PBM) Reform Act; S. 882, Patients Before Middlemen (PBM) Act; H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services (ECAPS) Act; H.R. 2484, Seniors Access to Critical Medications Act; IRA Medicare Drug Price Negotiation program implementation.

Defense

TRICARE pharmacy program.

Bills named in this filing 9

S. 526
Pharmacy Benefit Manager Transparency Act of 2025
H.R. 2214
DRUG Act
H.R. 1
One Big Beautiful Bill Act
H.R. 4317
PBM Reform Act of 2025
S. 882
Patients Before Middlemen Act
H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
H.R. 3164
Ensuring Community Access to Pharmacist Services Act
S. 2426
Equitable Community Access to Pharmacist Services Act
H.R. 2484
Seniors’ Access to Critical Medications Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.